.png)
Asia's menopause health platform · Singapore
Science-backed menopause support built for women in Asia Pacific
2 in 3 women affected at work and at home. 1 in 2 too stigmatised to speak up. We're here to change that.
Co-researched with NUS Bia-Echo ACRLE — the first real-world APAC study on menopause in the workplace.
Based in Singapore · Serving Asia Pacific
Research partner
NUS Bia-Echo Asia Centre for Reproductive Longevity & Equality (ACRLE) · Yong Loo Lin School of Medicine
Co-researched with NUS Bia-Echo Asia Centre for Reproductive Longevity & Equality (ACRLE) — first real-world APAC workplace menopause study · 1,741 respondents · 5 countries · 2025
Research backed
Trusted and supported by
For women in Singapore & Asia Pacific
Your menopause journey, supported by science
Track symptoms, access clinician-informed guidance, and prepare better conversations with your doctor, all in one place, built for Asian women's lived experience.
For HR leaders & employers in APAC
Build a menopause-inclusive workplace
Evidence-based workshops, policy frameworks, and tools that help HR leaders retain senior female talent and improve team performance across Asia Pacific.
The business case is clear
From the 2025 NUS ACRLE & HeyVenus study — 1,741 women across five APAC countries
67%
of APAC women aged 45+ say menopause symptoms disrupt their work performance and personal life
63%
of women experiencing menopause hold middle-to-senior leadership roles, your decision-makers
29%
of companies across Asia Pacific have a menopause or menstrual health-friendly policy in place
61%
report that social stigma is a barrier to discussing menopause symptoms at work — a defining challenge in Asia
Source: NUS Bia-Echo Asia Centre for Reproductive Longevity & Equality (ACRLE) & HeyVenus Integrated Healthscience, Menopause and the Bottom Line, April 2025. n=1,741 across Singapore, Japan, Indonesia, Vietnam & Australia.